From whiteboard to white coat: Roivant Social Ventures teams up with San Diego drug discovery center to bolster diversity in biopharmanews2022-03-24T13:29:41+00:00March 24th, 2022|FierceBiotech|
Pfizer grabs another breakthrough tag for RSV shot in older adultsnews2022-03-24T13:04:47+00:00March 24th, 2022|FierceBiotech|
Hookipa CEO waives 50% of salary in bet on brighter daysnews2022-03-24T12:34:41+00:00March 24th, 2022|FierceBiotech|
Orion staff brace for layoffs, program terminations after cancer and pain emerge as R&D starsnews2022-03-24T10:57:57+00:00March 24th, 2022|FierceBiotech|
Could a simple dietary supplement treat Alzheimer’s?news2022-03-23T18:23:28+00:00March 23rd, 2022|FierceBiotech|
Celsius turns up the heat with lead drug selection, $83M financingnews2022-03-23T17:46:06+00:00March 23rd, 2022|FierceBiotech|
Another Eylea rival struggles in phase 2, this time fielded by Ribomicnews2022-03-23T16:40:20+00:00March 23rd, 2022|FierceBiotech|
How creative chemistry and collaboration synthesized a better drug strategy for Enterinnews2022-03-23T14:49:27+00:00March 23rd, 2022|FierceBiotech|
After ‘masterful’ development of Keytruda, Merck’s CMO follows Roger Perlmutter to Eikonnews2022-03-23T14:23:48+00:00March 23rd, 2022|FierceBiotech|
2seventy bio’s honeymoon phase is over as job cuts hit 6% of staffnews2022-03-23T14:08:06+00:00March 23rd, 2022|FierceBiotech|
